UZ Brussel HRMC Registry of Brugada Syndrome
Launched by UNIVERSITAIR ZIEKENHUIS BRUSSEL · Mar 12, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The UZ Brussel HRMC Registry of Brugada Syndrome is a research study focused on collecting important information about patients who have been diagnosed with Brugada syndrome, a condition that affects the heart's electrical system and can lead to serious heart rhythm problems. This study is being conducted at UZ Brussel hospital and is currently looking for participants to join. People aged between 18 and 75 who have a confirmed diagnosis of Brugada syndrome may be eligible to take part, while those with different heart conditions will not be included.
Participants in this study can expect to provide their medical information, which will help researchers understand more about Brugada syndrome and improve care for future patients. By joining this registry, participants contribute to a valuable resource that aims to enhance knowledge and treatment options for this condition. Your involvement could make a difference in how doctors understand and manage Brugada syndrome in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Brugada syndrome diagnosis
- Exclusion Criteria:
- • Other diagnosis different from Brugada syndrome
About Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel) is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution affiliated with the Vrije Universiteit Brussel, UZ Brussel integrates cutting-edge medical research with high-quality patient care. The hospital's multidisciplinary teams are dedicated to exploring novel therapeutic approaches and contributing to the development of evidence-based treatments, ensuring the highest standards of safety and efficacy in clinical research. With a strong focus on collaboration and knowledge dissemination, UZ Brussel plays a pivotal role in shaping the future of medicine and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials